Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
Distal motor latency was significantly more prolonged in CMT1A patients compared to the CMT1C and HNPP groups, the latter two groups having similar distal motor latency values.
|
28211240 |
2017 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients were divided into three subtypes, CMT1, CMT2 and hereditary neuropathy with liability to pressure palsy (HNPP), according to their electrophysiological manifestations.
|
26454100 |
2015 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
Two patients showed rearrangements in the PMP22 gene, which is commonly associated with CMT1 or HNPP phenotypes thus usually not tested in CMT2 patients.
|
24819634 |
2014 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
The phenotype varied from mild hereditary neuropathy with liability to pressure palsies (HNPP) to severe CMT1.
|
21194947 |
2011 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
Electrophysiological examination revealed a demyelinating sensorimotor neuropathy, both resembling CMT1 and HNPP.
|
21692910 |
2011 |
Hereditary liability to pressure palsies
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The major Charcot- Marie-Tooth Type 1 (CMT1) locus, CMT1A, and Hereditary neuropathy with liability to pressure palsies (HNPP) cosegregate with a 1.5-Mb duplication and a 1.5-Mb deletion, respectively, in band 17p11.2.
|
11140841 |
2000 |
Hereditary liability to pressure palsies
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Using allele-specific PCR we identified 14 [allele frequency (AF)=0.007] in the German general population, one (AF=0.01) in the HNPP group and six (AF=0.016) and two (AF=0.05) carriers of the PMP22 Thr118Met mutation in the CMT1 groups with and without gene defect.
|
11081809 |
2000 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
We analysed the nerve specific promoter of the peripheral myelin protein 22 gene (PMP22) in a set of 15 unrelated patients with Charcot-Marie-Tooth type 1 disease (CMT1) and 16 unrelated patients with hereditary neuropathy with liability to pressure palsies (HNPP).
|
9678704 |
1998 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
As shown for the animal model of globoid cell dystrophy, it is conceivable that increased expression of MHC class II molecules in CMT1 and HNPP accelerates nerve pathology.
|
9771665 |
1998 |
Hereditary liability to pressure palsies
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The observation of a 1.5 Mb tandem duplication in chromosome 17p11.2, containing the PMP22 gene, in CMT1 and the reciprocal deletion in the same region in HNPP has provided a novel disease paradigm for autosomal dominant disorders, i.e. the gene dosage mechanism.
|
10975746 |
1997 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth type 1 disease (CMT1) and hereditary neuropathy with liability to pressure palsies (HNPP) are common inherited disorders of the peripheral nervous system.
|
9032649 |
1997 |
Hereditary liability to pressure palsies
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Point mutations in the coding region of the myelin genes, peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) or connexin 32 (Cx32) have been reported in CMT patients, including CMT type 1 (CMT1), CMT type 2 (CMT2) and Déjérine-Sottas neuropathy (DS) patients, and only in the coding region of PMP22 in HNPP families lacking a deletion.
|
9187667 |
1997 |
Hereditary liability to pressure palsies
|
0.100 |
Biomarker
|
disease |
BEFREE |
There are reports of central conduction abnormalities in CMT 1, however, there have been no previous reports of central nervous system (CNS) demyelination in HNPP.
|
8609929 |
1996 |